Ultrasound for gastroenterologists.
D F Martin
Gut 1996; 38: 479-480. doi:10.1136/gut.38.4.479
[PDF]
[Request Permissions]
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
N I McDougall, B T Johnston, F Kee, J S Collins, R J McFarland, and A H Love
Gut 1996; 38: 481-486. doi:10.1136/gut.38.4.481
[Abstract]
[PDF]
[Request Permissions]
Laparoscopic Nissen fundoplication--200 consecutive cases.
D C Gotley, B M Smithers, M Rhodes, B Menzies, F J Branicki, and L Nathanson
Gut 1996; 38: 487-491. doi:10.1136/gut.38.4.487
[Abstract]
[PDF]
[Request Permissions]
Effect of acute stress on oesophageal motility in patients with gastro-oesophageal reflux disease.
B T Johnston, R J McFarland, J S Collins, and A H Love
Gut 1996; 38: 492-497. doi:10.1136/gut.38.4.492
[Abstract]
[PDF]
[Request Permissions]
Induction of gastric epithelial apoptosis by Helicobacter pylori.
S F Moss, J Calam, B Agarwal, S Wang, and P R Holt
Gut 1996; 38: 498-501. doi:10.1136/gut.38.4.498
[Abstract]
[PDF]
[Request Permissions]
Gastric mucosal superoxide dismutases in Helicobacter pylori infection.
J M Götz, C I van Kan, H W Verspaget, I Biemond, C B Lamers, and R A Veenendaal
Gut 1996; 38: 502-506. doi:10.1136/gut.38.4.502
[Abstract]
[PDF]
[Request Permissions]
Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation.
X Fan, A Long, M Goggins, X Fan, P W Keeling, and D Kelleher
Gut 1996; 38: 507-512. doi:10.1136/gut.38.4.507
[Abstract]
[PDF]
[Request Permissions]
Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori.
S M Gormally, B M Kierce, L E Daly, B Bourke, R Carroll, M T Durnin, and B Drumm
Gut 1996; 38: 513-517. doi:10.1136/gut.38.4.513
[Abstract]
[PDF]
[Request Permissions]
Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.
M E McAlindon, A F Muller, B Filipowicz, and C J Hawkey
Gut 1996; 38: 518-524. doi:10.1136/gut.38.4.518
[Abstract]
[PDF]
[Request Permissions]
Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma.
C W Wu, M C Hsieh, S S Lo, S H Tsay, W Y Lui, and F K P'eng
Gut 1996; 38: 525-527. doi:10.1136/gut.38.4.525
[Abstract]
[PDF]
[Request Permissions]
Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease.
P Collin, E Pukkala, and T Reunala
Gut 1996; 38: 528-530. doi:10.1136/gut.38.4.528
[Abstract]
[PDF]
[Request Permissions]
Comparative effects of dietary nucleoside-nucleotide mixture and its components on endotoxin induced bacterial translocation and small intestinal injury in protein deficient mice.
A A Adjei, K Yamauchi, Y C Chan, M Konishi, and S Yamamoto
Gut 1996; 38: 531-537. doi:10.1136/gut.38.4.531
[Abstract]
[PDF]
[Request Permissions]
HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany.
M Reinshagen, C Loeliger, P Kuehnl, U Weiss, B J Manfras, G Adler, and B O Boehm
Gut 1996; 38: 538-542. doi:10.1136/gut.38.4.538
[Abstract]
[PDF]
[Request Permissions]
Supplementary enteral nutrition maintains remission in paediatric Crohn's disease.
M Wilschanski, P Sherman, P Pencharz, L Davis, M Corey, and A Griffiths
Gut 1996; 38: 543-548. doi:10.1136/gut.38.4.543
[Abstract]
[PDF]
[Request Permissions]
Leucocyte typing, cytokine expression, and epithelial turnover in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis.
P A Goldberg, F Herbst, C G Beckett, B Martelli, M Kontakou, I C Talbot, P J Ciclitira, and R J Nicholls
Gut 1996; 38: 549-553. doi:10.1136/gut.38.4.549
[Abstract]
[PDF]
[Request Permissions]
MUC2 is the prominent colonic mucin expressed in ulcerative colitis.
K M Tytgat, F J Opdam, A W Einerhand, H A Büller, and J Dekker
Gut 1996; 38: 554-563. doi:10.1136/gut.38.4.554
[Abstract]
[PDF]
[Request Permissions]
Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.
D W Hommes, J Meenan, M de Haas, F J ten Kate, A E von dem Borne, G N Tytgat, and S J van Deventer
Gut 1996; 38: 564-567. doi:10.1136/gut.38.4.564
[Abstract]
[PDF]
[Request Permissions]
Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.
J D Butzner, R Parmar, C J Bell, and V Dalal
Gut 1996; 38: 568-573. doi:10.1136/gut.38.4.568
[Abstract]
[PDF]
[Request Permissions]
Outcome of restorative proctocolectomy with ileal reservoir for ulcerative colitis: comparison of distal colitis with more proximal disease.
D N Samarasekera, J F Stebbing, M G Kettlewell, D P Jewell, and N J Mortensen
Gut 1996; 38: 574-577. doi:10.1136/gut.38.4.574
[Abstract]
[PDF]
[Request Permissions]
Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
F M Giardiello, J A Offerhaus, A C Tersmette, L M Hylind, A J Krush, J D Brensinger, S V Booker, and S R Hamilton
Gut 1996; 38: 578-581. doi:10.1136/gut.38.4.578
[Abstract]
[PDF]
[Request Permissions]
Effects of longterm epidermal growth factor treatment on the normal rat colon.
P Kissmeyer-Nielsen, L Vinter-Jensen, and M Smerup
Gut 1996; 38: 582-586. doi:10.1136/gut.38.4.582
[Abstract]
[PDF]
[Request Permissions]
Pathology of the rectal wall in solitary rectal ulcer syndrome and complete rectal prolapse.
Y S Kang, M A Kamm, A F Engel, and I C Talbot
Gut 1996; 38: 587-590. doi:10.1136/gut.38.4.587
[Abstract]
[PDF]
[Request Permissions]
Faecal phytic acid and its relation to other putative markers of risk for colorectal cancer.
R W Owen, U M Weisgerber, B Spiegelhalder, and H Bartsch
Gut 1996; 38: 591-597. doi:10.1136/gut.38.4.591
[Abstract]
[PDF]
[Request Permissions]
Decrease in sensitisation rate and intestinal anaphylactic response after nitric oxide synthase inhibition in a food hypersensitivity model.
M J Fargeas, V Theodorou, B Weirich, J Fioramonti, and L Buéno
Gut 1996; 38: 598-602. doi:10.1136/gut.38.4.598
[Abstract]
[PDF]
[Request Permissions]
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.
J M Sánchez-Tapias, X Forns, S Ampurdanés, L Titó, R Planas, J M Viver, D Acero, M Torres, P Mas, R Morillas, M Forné, J Espinós, J M Llovet, J Costa, E Olmedo, F X López-Labrador, M T Jiménez de Anta, and J Rodés
Gut 1996; 38: 603-609. doi:10.1136/gut.38.4.603
[Abstract]
[PDF]
[Request Permissions]
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
U Broomé, R Olsson, L Lööf, G Bodemar, R Hultcrantz, A Danielsson, H Prytz, H Sandberg-Gertzén, S Wallerstedt, and G Lindberg
Gut 1996; 38: 610-615. doi:10.1136/gut.38.4.610
[Abstract]
[PDF]
[Request Permissions]
Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.
F W Leebeek, R J Ouwendijk, A H Kolk, A Dees, J C Meek, J E Nienhuis, and A M Dingemans-Dumas
Gut 1996; 38: 616-618. doi:10.1136/gut.38.4.616
[Abstract]
[PDF]
[Request Permissions]
Colitis complicating chronic granulomatous disease. A clinicopathological case report.
J M Sloan, C H Cameron, R J Maxwell, D R McCluskey, and J S Collins
Gut 1996; 38: 619-622. doi:10.1136/gut.38.4.619
[Abstract]
[PDF]
[Request Permissions]
Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
P T Clayton, K A Mills, A W Johnson, A Barabino, and M G Marazzi
Gut 1996; 38: 623-628. doi:10.1136/gut.38.4.623
[Abstract]
[PDF]
[Request Permissions]